Volume 10, Issue 5, Pages (May 2012)

Slides:



Advertisements
Similar presentations
Structure of a Ubiquitin E1-E2 Complex: Insights to E1-E2 Thioester Transfer Shaun K. Olsen, Christopher D. Lima Molecular Cell Volume 49, Issue 5, Pages.
Advertisements

SOD1 Integrates Signals from Oxygen and Glucose to Repress Respiration Amit R. Reddi, Valeria C. Culotta Cell Volume 152, Issue 1, Pages (January.
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Distinct Self-Renewal and Differentiation Phases in the Niche of Infrequently Dividing Hair Follicle Stem Cells Ying V. Zhang, Janice Cheong, Nichita Ciapurin,
Bone Marrow-Derived Cell Therapy Stimulates Endogenous Cardiomyocyte Progenitors and Promotes Cardiac Repair Francesco S. Loffredo, Matthew L. Steinhauser,
Distribution of Human Embryonic Stem Cell Lines: Who, When, and Where Jennifer B. McCormick, Jason Owen-Smith, Christopher Thomas Scott Cell Stem Cell.
Prediction and Testing of Novel Transcriptional Networks Regulating Embryonic Stem Cell Self-Renewal and Commitment Emily Walker, Minako Ohishi, Ryan E.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
Stocks, Stocks, Stocks. How can you track the value of stocks? Stock quotes are used to track how stocks are performing in the market.
Module Map of Stem Cell Genes Guides Creation of Epithelial Cancer Stem Cells David J. Wong, Helen Liu, Todd W. Ridky, David Cassarino, Eran Segal, Howard.
IPSC Crowdsourcing: A Model for Obtaining Large Panels of Stem Cell Lines for Screening Mahendra Rao Cell Stem Cell Volume 13, Issue 4, Pages (October.
 52-Week Hi & Low  Highest & lowest selling price of the stock during the preceding 52 week  Company Name/Name of Stock  Ticker Symbol  Unique alphabetic.
Human Brown Adipose Tissue Sven Enerbäck Cell Metabolism Volume 11, Issue 4, Pages (April 2010) DOI: /j.cmet Copyright © 2010.
“Stocks”. STOCKS, STOCKS, STOCKS How can you track the value of stocks? Stock quotes are used to track how stocks are performing in the market.
Fate Restriction and Multipotency in Retinal Stem Cells Lázaro Centanin, Burkhard Hoeckendorf, Joachim Wittbrodt Cell Stem Cell Volume 9, Issue 6, Pages.
The Mitochondrial Basis of Aging Nuo Sun, Richard J. Youle, Toren Finkel Molecular Cell Volume 61, Issue 5, Pages (March 2016) DOI: /j.molcel
Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle Isabel Beerman, Jun Seita, Matthew A.
Germline Energetics, Aging, and Female Infertility Jonathan L. Tilly, David A. Sinclair Cell Metabolism Volume 17, Issue 6, Pages (June 2013) DOI:
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells Keriayn N. Smith, Amar M. Singh, Stephen Dalton Cell Stem Cell Volume 7, Issue.
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Gastrulation Movements: the Logic and the Nuts and Bolts Maria Leptin Developmental Cell Volume 8, Issue 3, Pages (March 2005) DOI: /j.devcel
Quantitative Single-Cell Approaches to Stem Cell Research Martin Etzrodt, Max Endele, Timm Schroeder Cell Stem Cell Volume 15, Issue 5, Pages (November.
Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey 
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
Stress Can Be a Good Thing for Blood Formation
Kevin G. Chen, Barbara S. Mallon, Ronald D.G. McKay, Pamela G. Robey 
Scott N. Freeman, Kathryn A. Burke, Menfo A. Imoisili, Timothy R. Coté 
Leigh Turner, Paul Knoepfler  Cell Stem Cell 
Volume 1, Issue 1, Pages (June 2007)
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
A Path to Insulin Independence: “The End of the Beginning”
Volume 12, Issue 6, Pages (June 2013)
Volume 9, Issue 2, Pages (August 2011)
Gerry P. Crossan, Juan I. Garaycoechea, Ketan J. Patel  Cell Stem Cell 
New Japanese Initiatives on Stem Cell Therapies
Public Private Partnerships: A Marriage of Necessity
Natalia J. Martinez, Richard I. Gregory  Cell Stem Cell 
Transplantable Liver Organoids Made from Only Three Ingredients
Regulating Cancer Stem Cells the miR Way
Wing Y. Chang, William L. Stanford  Cell Stem Cell 
Guillaume Richard-Carpentier, Guy Sauvageau  Cell Stem Cell 
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Why Myc? An Unexpected Ingredient in the Stem Cell Cocktail
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
MicroRNA Regulation of Stem Cell Fate
Volume 16, Issue 2, Pages (February 2015)
Putting Two Heads Together to Build a Better Brain
Stem Cell Therapies: California Dreamin'?
Volume 18, Issue 2, Pages (February 2016)
Volume 11, Issue 6, Pages (December 2012)
Volume 152, Issue 1, (January 2013)
Transplantable Liver Organoids Made from Only Three Ingredients
The Promise and Perils of Stem Cell Therapeutics
Powering Reprogramming with Vitamin C
Volume 16, Issue 1, Pages (January 2015)
NO Signals from the Cancer Stem Cell Niche
Waddington’s Valleys and Captain Cook’s Islands
Selfish Stem Cells Compete with Each Other
The Side Story of Stem-like Glioma Cells
Chapter 29 - Stem Cells and Generation of New Cells in the
2008–2009 ISSCR Initiatives: Facilitating Communication and Education
Jeremy Sugarman, Andrew Siegel  Cell Stem Cell 
Volume 11, Issue 6, Pages (December 2012)
David Hubel and Torsten Wiesel
Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason  Cell Stem Cell 
Getting to the Core of Repeat Expansions by Cell Reprogramming
Notching Up MYC Gives a LIC
Volume 148, Issue 1, (January 2012)
Presentation transcript:

Volume 10, Issue 5, Pages 492-496 (May 2012) Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012  David A. Brindley, Natasha L. Davie, William A. Sahlman, Gregory A. Bonfiglio, Emily J. Culme-Seymour, Brock C. Reeve, Chris Mason  Cell Stem Cell  Volume 10, Issue 5, Pages 492-496 (May 2012) DOI: 10.1016/j.stem.2012.04.018 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 The Change in Stock Price of Individual, publicly Traded Cell Therapy Companies from January 1 to March 31, 2012 White bars represent an overall increase in stock price and red bars represent an overall decrease. Vertical lines correspond to the maximum and minimum share prices attained throughout the quarter. Values in brackets next to company names represent the market capitalization of the company (in millions of dollars). The company order is alphabetized as per their stock ticker symbols. See also Table S1. Cell Stem Cell 2012 10, 492-496DOI: (10.1016/j.stem.2012.04.018) Copyright © 2012 Elsevier Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.